Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

Cited by (1,029)

Items 401–500 of 1,029

1. The Genetics of Alzheimer Disease
   Deborah Blacker, Rudolph E. Tanzi · 1998 · Archives of Neurology
2. From combinations to multitarget-directed ligands: A continuum in Alzheimer’s disease polypharmacology
   Albertini, Claudia, Salerno, Alessandra, de Sena Murteira Pinheiro, Pedro, Bolognesi, Maria L. · 2021 · Medicinal Research Reviews
3. Dense-Core Plaques in Tg2576 and PSAPP Mouse Models of Alzheimer's Disease Are Centered on Vessel Walls
   Samir Kumar‐Singh, Daniel Nicolae Pirici, Eileen M. McGowan, Sally Serneels, C. Ceuterick, John Hardy, Karen Duff, Dennis W. Dickson, Christine Van Broeckhoven · 2005 · American Journal Of Pathology
4. Transgenic mouse models of alzheimer disease: Developing a better model as a tool for therapeutic interventions.
   Kitazawa, Masashi, Medeiros, Rodrigo, M. LaFerla, Frank · 2012 · Current Pharmaceutical Design
5. Transgenic mouse models of Alzheimer's disease
   Christopher Janus, David A. Westaway · 2001 · Physiology & Behavior
6. The presenilin-1 ΔE9 mutation results in reduced γ-secretase activity, but not total loss of PS1 function, in isogenic human stem cells
   Woodruff, Grace, Young, Jessica E., Martinez, Fernando J., Buen, Floyd, Gore, Athurva, Kinaga, Jennifer, Li, Zhe, Yuan, Shauna H., Zhang, Kun, Goldstein, Lawrence S.B. · 2013 · Cell Reports
7. Apolipoprotein E4 Potentiates Amyloid β Peptide-induced Lysosomal Leakage and Apoptosis in Neuronal Cells
   Ji, Zhong-Sheng, Miranda, R. Dennis, Newhouse, Yvonne M., Weisgraber, Karl H., Huang, Yadong, Mahley, Robert W. · 2002 · Journal of Biological Chemistry
8. Chronic stress as a risk factor for Alzheimer’s disease
   Alberto Machado, Antonio J. Herrera, Rocío M. de Pablos, Ana M. Espinosa‐Oliva, Manuel Sarmiento Soto, Antonio Ayala, Jose Luis Venero, Martiniano Santiago, Ruth F. Villarán, María José Delgado‐Cortés et al. · 2014 · Reviews in the Neurosciences
9. β-Amyloid Immunotherapy Prevents Synaptic Degeneration in a Mouse Model of Alzheimer's Disease
   Buttini, Manuel, Masliah, Eliezer, Barbour, Robin, Grajeda, Henry, Motter, Ruth, Johnson-Wood, Kelly, Khan, Karen, Seubert, Peter, Freedman, Stephen, Schenk, Dale et al. · 2005 · The Journal of Neuroscience
10. Anti-Aβ Drug Screening Platform Using Human iPS Cell-Derived Neurons for the Treatment of Alzheimer's Disease
    Naoki Yahata, Masashi Asai, Shiho Kitaoka, Kazutoshi Takahashi, Isao Asaka, Hiroyuki Hioki, Takeshi Kaneko, Kei Maruyama, Takaomi C. Saido, Tatsutoshi Nakahata et al. · 2011 · PLoS ONE
11. Behavioral phenotypes of amyloid‐based genetically modified mouse models of Alzheimer's disease
    Dione T. Kobayashi, K. S. Chen · 2005 · Genes Brain & Behavior
12. Degradation of Amyloid β-Protein by a Metalloprotease Secreted by Microglia and Other Neural and Non-neural Cells
    Wei Qiao Qiu, Zhen Ye, Dora Kholodenko, Peter A. Seubert, Dennis J. Selkoe · 1997 · Journal of Biological Chemistry
13. Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia
    Ferrer, Isidro · 2012 · Progress in Neurobiology
14. ‘Too much good news’ – are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer's disease?
    Kathleen R. Zahs, Karen H. Ashe · 2010 · Trends in Neurosciences
15. Inflammation and neurovascular changes in amyotrophic lateral sclerosis
    Matthew C. Evans, Yvonne Couch, Nicola R. Sibson, Martin R. Turner · 2012 · Molecular and Cellular Neuroscience
16. Ectopic Cell Cycle Events Link Human Alzheimer's Disease and Amyloid Precursor Protein Transgenic Mouse Models
    Yan Yang, Nicholas H. Varvel, Bruce T. Lamb, Karl Herrup · 2006 · Journal of Neuroscience
17. Modulation of Aβ peptides by estrogen in mouse models
    Hui Zheng, Huaxi Xu, Sacha Uljon, R. Gross, Katrina Gwinn Hardy, J. Gaynor, John J. LaFrancois, James W. Simpkins, Lorenzo M. Refolo, Suzana S. Petanceska et al. · 2001 · Journal of Neurochemistry
18. In Vivo Imaging of Reactive Oxygen Species Specifically Associated with Thioflavine S-Positive Amyloid Plaques by Multiphoton Microscopy
    McLellan, Megan E., Kajdasz, Stephen T., Hyman, Bradley T., Bacskai, Brian J. · 2003 · The Journal of Neuroscience
19. Hemizygous minipigs produced by random gene insertion and handmade cloning express the Alzheimer’s disease-causing dominant mutation APPsw
    Peter M. Kragh, Anders Lade Nielsen, Juan Li, Yutao Du, Lin Lin, Mette H. Schmidt, Ingrid Brück Bøgh, Ida E. Holm, Jannik Ejnar Jakobsen, Marianne Johansen et al. · 2009 · Transgenic Research
20. Stable Association of Presenilin Derivatives and Absence of Presenilin Interactions with APP
    Gopal Thinakaran, Jean B. Regard, Christopher M. L. S. Bouton, Christie L. Harris, Donald L. Price, David Borchelt, Sangram S. Sisodia · 1998 · Neurobiology of Disease
21. Key Factors in Alzheimer's Disease: β‐amyloid Precursor Protein Processing, Metabolism and Intraneuronal Transport
    Thomas A. Bayer, Oliver Wirths, Katalin Majtényi, Tobias Hartmann, Gerd Multhaup, Konrad T. Beyreuther, Christian Czech · 2001 · Brain Pathology
22. Withanoside IV and its active metabolite, sominone, attenuate Aβ(25–35)‐induced neurodegeneration
    Kuboyama, Tomoharu, Tohda, Chihiro, Komatsu, Katsuko · 2006 · European Journal of Neuroscience
23. A Systematic Review of Glucose Transport Alterations in Alzheimer's Disease
    Kyrtata, Natalia, Emsley, Hedley C. A., Sparasci, Oli, Parkes, Laura M., Dickie, Ben R. · 2021 · Frontiers in Neuroscience
24. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies
    Michel Goedert · 1999 · Philosophical Transactions of the Royal Society B Biological Sciences
25. Suppression of brain aging and neurodegenerative disorders by dietary restriction and environmental enrichment: molecular mechanisms
    Mark P. Mattson · 2001 · Mechanisms of Ageing and Development
26. Diffusion tensor imaging detects age-dependent white matter changes in a transgenic mouse model with amyloid deposition
    Song, Sheng-Kwei, Kim, Joong Hee, Lin, Shiow-Jiuan, Brendza, Robert P., Holtzman, David M. · 2004 · Neurobiology of Disease
27. Neuroplasticity in Alzheimer's disease
    Teter, Bruce, Ashford, J. Wesson · 2002 · Journal of Neuroscience Research
28. Amyloid deposition in the hippocampus and entorhinal cortex: Quantitative analysis of a transgenic mouse model
    John F. Reilly, Dora Games, Russell E. Rydel, Stephen B. Freedman, Dale Schenk, Warren G. Young, John H. Morrison, Floyd E. Bloom · 2003 · Proceedings of the National Academy of Sciences
29. Morphological Characterization of Thioflavin-S-Positive Amyloid Plaques in Transgenic Alzheimer Mice and Effect of Passive Aβ Immunotherapy on Their Clearance
    Thierry Bussière, Frédérique Bard, Robin Barbour, Henry Grajeda, Terry Guido, Karen Khan, Dale Schenk, Dora Games, Peter A. Seubert, Manuel Buttini · 2004 · American Journal Of Pathology
30. Lysosomal Sorting of Amyloid-β by the SORLA Receptor Is Impaired by a Familial Alzheimer’s Disease Mutation
    Caglayan, Safak, Takagi-Niidome, Shizuka, Liao, Fan, Carlo, Anne-Sophie, Schmidt, Vanessa, Burgert, Tilman, Kitago, Yu, Füchtbauer, Ernst-Martin, Füchtbauer, Annette, Holtzman, David M. et al. · 2014 · Science Translational Medicine
31. Brain Parenchymal and Microvascular Amyloid in Alzheimer's Disease
    Harry V. Vinters, Zhen Zhen Wang, Diana Lenard Secor · 1996 · Brain Pathology
32. The role of apolipoprotein E in Alzheimer’s disease, acute brain injury and cerebrovascular disease: evidence of common mechanisms and utility of animal models
    Karen J. Horsburgh, Mark O. McCarron, Fiona White, James A. R. Nicoll · 2000 · Neurobiology of Aging
33. Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology
    Jeroen J.M. Hoozemans, Robert Veerhuis, Annemieke J.M. Rozemüller, Piet Eikelenboom · 2005 · International Journal of Developmental Neuroscience
34. Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe/PS1ΔE9-deleted transgenic mice model of β-amyloidosis
    Arturas Volianskis, Rasmus Køstner, Morten Mølgaard, Susanne Hass, Morten S. Jensen · 2008 · Neurobiology of Aging
35. Role of Caspases in N‐Methyl‐ d ‐Aspartate‐Induced Apoptosis in Cerebrocortical Neurons
    Lalitha Tenneti, Danielle M. D’Emilia, Carol M. Troy, Stuart A. Lipton · 1998 · Journal of Neurochemistry
36. Mechanism of Cerebral β-Amyloid Angiopathy: Murine and Cellular Models
    Martin C. Herzig, William E. Van Nostrand, Mathias Jucker · 2006 · Brain Pathology
37. A Becn1 mutation mediates hyperactive autophagic sequestration of amyloid oligomers and improved cognition in Alzheimer's disease
    Rocchi, Altea, Yamamoto, Soh, Ting, Tabitha, Fan, Yuying, Sadleir, Katherine, Wang, Yigang, Zhang, Weiran, Huang, Sui, Levine, Beth, Vassar, Robert et al. · 2017 · PLOS Genetics
38. The Basal Forebrain Cholinergic Projection System in Mice
    László Záborszky, Anthony N. van den Pol, Erika Gyengési · 2011 · Elsevier eBooks
39. Structure of tau protein and assembly into paired helical filaments
    Peter Friedhoff, Martin von Bergen�, Eva‐Maria Mandelkow, Eckhard Mandelkow · 2000 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
40. Cognitive and behavioural effects of physical exercise in psychiatric patients
    Christian Knöchel, Viola Oertel‐Knöchel, Laurence O’Dwyer, David Prvulovic, Gilberto Sousa Alves, Bianca Kollmann, Harald Juergen Hampel · 2011 · Progress in Neurobiology
41. The presenilin genes: a new gene family involved in Alzheimer disease pathology
    Cruts, Marc, Hendriks, Lydia, Van Broeckhoven, Christine · 1996 · Human Molecular Genetics
42. Disrupting β-Amyloid Aggregation for Alzheimer Disease Treatment
    Lisbell D. Estrada, Claudio A. Soto · 2006 · Current Topics in Medicinal Chemistry
43. Human antibodies against amyloid β peptide: A potential treatment for Alzheimer's disease
    Richard C. Dodel, Harald Juergen Hampel, Candan Depboylu, Suizhen Lin, Feng Gao, Sabine Schock, Steffi Jäckel, Xing Wei, Katharina Büerger, Christine Höft et al. · 2002 · Annals of Neurology
44. Amyloidogenic processing of the human amyloid precursor protein in primary cultures of rat hippocampal neurons.
    Simons, M, de Strooper, B, Multhaup, G, Tienari, PJ, Dotti, CG, Beyreuther, K · 1996 · The Journal of Neuroscience
45. Tau and transgenic animal models
    Jürgen Götz · 2001 · Brain Research Reviews
46. Cholinergic Changes in the APP23 Transgenic Mouse Model of Cerebral Amyloidosis
    Boncristiano, Sonia, Calhoun, Michael E., Kelly, Peter H., Pfeifer, Michelle, Bondolfi, Luca, Stalder, Martina, Phinney, Amie L., Abramowski, Dorothee, Sturchler-Pierrat, Christine, Enz, Albert et al. · 2002 · The Journal of Neuroscience
47. Apolipoprotein E Markedly Facilitates Age-Dependent Cerebral Amyloid Angiopathy and Spontaneous Hemorrhage in Amyloid Precursor Protein Transgenic Mice
    Fryer, John D., Taylor, Jennie W., DeMattos, Ronald B., Bales, Kelly R., Paul, Steven M., Parsadanian, Maia, Holtzman, David M. · 2003 · The Journal of Neuroscience
48. Identification of Septins in Neurofibrillary Tangles in Alzheimer's Disease
    Ayae Kinoshita, Makoto Kinoshita, Haruhiko Akiyama, Hidekazu Tomimoto, Ichiro Akiguchi, Sharad Kumar, Makoto Noda, Jun Kimura · 1998 · American Journal Of Pathology
49. Specific spatial learning deficits become severe with age in β-amyloid precursor protein transgenic mice that harbor diffuse β-amyloid deposits but do not form plaques
    Milla Koistinaho, Michael Ort, José Manuel Cimadevilla, Roman Vondrous, Barbara Cordell, Jari Koıstınaho, Jan Bureš, Linda Slanec Higgins · 2001 · Proceedings of the National Academy of Sciences
50. β-Amyloid precursor protein transgenic mice that harbor diffuse Aβ deposits but do not form plaques show increased ischemic vulnerability: Role of inflammation
    Koistinaho, Milla, Kettunen, Mikko I., Goldsteins, Gundars, Keinänen, Riitta, Salminen, Antero, Ort, Michael, Bures, Jan, Liu, David, Kauppinen, Risto A., Higgins, Linda S. et al. · 2002 · Proceedings of the National Academy of Sciences
51. Amyloid β-peptide polymerization studied using fluorescence correlation spectroscopy
    Lars O. Tjernberg, Aladdin Pramanik, Sofie C. Björling, Per Thyberg, Johan Thyberg, Christer Nordstedt, Kurt D. Berndt, Lars Y. Terenius, Rudolf W. Rigler · 1999 · Chemistry & Biology
52. The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APPSW mice
    Wegiel, J · 2001 · Neurobiology of Aging
53. Genetic Modification of the Phenotypes Produced by Amyloid Precursor Protein Overexpression in Transgenic Mice
    Carlson, G. A., Borchelt, D. R., Dake, A., Turner, S., Danielson, V., Coffin, J. D., Eckman, C., Meiners, J., Nilsen, S. P., Younkin, S. G. et al. · 1997 · Human Molecular Genetics
54. Convergence of Amyloid-β and Tau Pathologies on Mitochondria In Vivo
    Anne Eckert, Kathrin L. Schulz, Virginie F. Rhein, Jürgen Götz · 2010 · Molecular Neurobiology
55. Antioxidant Therapy in Alzheimers Disease: Theory and Practice
    Gjumrakch Aliev, Mark E. Obrenovich, V. Prakash Reddy, Justin C. Shenk, Paula Isabel Moreira, Akihiko Nunomura, Xiongwei Zhu, Mark A. Smith, George L. Perry · 2008 · Mini-Reviews in Medicinal Chemistry
56. Conditional Inactivation of Presenilin 1 Prevents Amyloid Accumulation and Temporarily Rescues Contextual and Spatial Working Memory Impairments in Amyloid Precursor Protein Transgenic Mice
    Saura, Carlos A., Chen, Guiquan, Malkani, Seema, Choi, Se-Young, Takahashi, Reisuke H., Zhang, Dawei, Gouras, Gunnar K., Kirkwood, Alfredo, Morris, Richard G. M., Shen, Jie · 2005 · The Journal of Neuroscience
57. Statins and cognitive function in the elderly
    Charles B. Bernick, Ronit Katz, N. L. Smith, Steve Rapp, Rafeeque A Bhadelia, M. C. Carlson, Lewis H. Kuller · 2005 · Neurology
58. Point Substitution in the Central Hydrophobic Cluster of a Human β-Amyloid Congener Disrupts Peptide Folding and Abolishes Plaque Competence
    William P. Esler, Evelyn R. Stimson, Joseph R. Ghilardi, Yi-An Lu, Arthur M. Felix, Harry V. Vinters, Patrick W. Mantyh, Jonathan P. Lee, John E. Maggio · 1996 · Biochemistry
59. The molecular and genetic basis of AD: The end of the beginning
    Roger N. Rosenberg · 2000 · Neurology
60. Cell division in the CNS: Protective response or lethal event in post-mitotic neurons?
    Yan Yang, Karl Herrup · 2006 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
61. Transgenic Drosophila expressing human amyloid precursor protein show γ-secretase activity and a blistered-wing phenotype
    Anke Fossgreen, Bodo Brückner, Christian Czech, Colin Louis Masters, Konrad T. Beyreuther, Renato Paro · 1998 · Proceedings of the National Academy of Sciences
62. Neurovascular function in Alzheimer's disease patients and experimental models
    Nicolakakis, Nektaria, Hamel, Edith · 2011 · Journal of Cerebral Blood Flow & Metabolism
63. Animal models of Alzheimer’s disease: Applications, evaluation, and perspectives
    Chen, Zhi-Ya, 北京大学生命科学学院膜生物学国家重点实验室, 北京 100871, 中国, State Key Laboratory of Membrane Biology, College of Life Sciences, Peking University, Beijing 100871, China, Zhang, Yan · 2022 · Zoological Research
64. Adeno-associated virus vectors: activity and applications in the CNS
    Alyson L. Peel, Ronald L. Klein · 2000 · Journal of Neuroscience Methods
65. Role of Potassium Channels in Amyloid‐Induced Cell Death
    Luis V. Colom, Maria E. Diaz, David R. Beers, Alan Neely, Wenjie Xie, Stanley H. Appel · 1998 · Journal of Neurochemistry
66. Regulated secretion of beta-amyloid precursor protein in rat brain
    SA Farber, Roger M. Nitsch, JG Schulz, Richard Jay Wurtman · 1995 · Journal of Neuroscience
67. NK Cells in Healthy Aging and Age-Associated Diseases
    Xavier Camous, Alejandra Pera, Rafael Solana, Anis Larbi · 2012 · BioMed Research International
68. Pathology of the Aging Brain in Domestic and Laboratory Animals, and Animal Models of Human Neurodegenerative Diseases
    Sameh A. Youssef, Maria Tresa Capucchio, Jaime Rofina, James Kenn CHAMBERS, Kazuyuki Uchida, Hiroyuki Nakayama, Elizabeth Head · 2016 · Veterinary Pathology
69. Increased Cerebral Infarct Volumes in Polyglobulic Mice Overexpressing Erythropoietin
    Christoph Wießner, Peter Roland ALLEGRINI, Dimitrios Ekatodramis, Ursula R. Jewell, Thomas Stallmach, Max Gassmann · 2001 · Journal of Cerebral Blood Flow & Metabolism
70. Flavonoid‐mediated presenilin‐1 phosphorylation reduces Alzheimer's disease β‐amyloid production
    Kavon P. Rezai-Zadeh, R. Douglas Shytle, Yun Bai, Jun Tian, Huayan Hou, Takashi Mori, Jin Zeng, Demian F. Obregon, Terrence Town, Jun Tan · 2008 · Journal of Cellular and Molecular Medicine
71. Molecular Structure of a Fibrillar Alzheimer's Aβ Fragment
    Louise C. Serpell, Colin Blake, Paul E. Fraser · 2000 · Biochemistry
72. Aβ as a bioflocculant: implications for the amyloid hypothesis of Alzheimer’s disease
    Stephen R. Robinson, Glenda M. Bishop · 2002 · Neurobiology of Aging
73. The Genetics of the Amyloidoses
    Joel N. Buxbaum, Clément E. Tagoe · 2000 · Annual Review of Medicine
74. BACE1 (β-secretase) transgenic and knockout mice: identification of neurochemical deficits and behavioral changes
    Harrison, Steve M, Harper, Alex J, Hawkins, Julie, Duddy, Graham, Grau, Evelyn, Pugh, Pippa L, Winter, Panida H, Shilliam, Claire S, Hughes, Zoë A, Dawson, Lee A et al. · 2003 · Molecular and Cellular Neuroscience
75. Cultured glial cells express the SNAP-25 analogue SNAP-23
    Régine Hepp, Martine Perraut, Sylvette Chasserot‐Golaz, Thierry Galli, Dominique Aunis, Keith Langley, Nancy J. Grant · 1999 · Glia
76. The Cholinergic Deficit Coincides with Aβ Deposition at the Earliest Histopathologic Stages of Alzheimer Disease
    Thomas G. Beach, Yu‐Min Kuo, Katharyn Spiegel, Mark R. Emmerling, Lucia I. Sue, K Kokjohn, Alex E. Roher · 2000 · Journal of Neuropathology & Experimental Neurology
77. Amyloid-β1–42 oligomer accelerates senescence in adult hippocampal neural stem/progenitor cells via formylpeptide receptor 2
    He, N, Jin, W-L, Lok, K-H, Wang, Y, Yin, M, Wang, Z-J · 2013 · Cell Death & Disease
78. Pharmacological inhibition of O-GlcNAcase (OGA) prevents cognitive decline and amyloid plaque formation in bigenic tau/APP mutant mice
    Scott A. Yuzwa, Xiaoyang Shan, Bryan A Jones, Gang Zhao, Melissa L. Woodward, Xiaojing Li, Yanping Zhu, Ernest J. McEachern, Michael A Silverman, Neil V. Watson et al. · 2014 · Molecular Neurodegeneration
79. Inflammation-Dependent Cerebral Deposition of Serum Amyloid A Protein in a Mouse Model of Amyloidosis
    Jun-tao Guo, Jin Yu, David Grass, Frederick C. de Beer, Mark S. Kindy · 2002 · Journal of Neuroscience
80. Enhanced Amyloidogenic Processing of the β-Amyloid Precursor Protein in Gene-targeted Mice Bearing the Swedish Familial Alzheimer's Disease Mutations and a “Humanized” Aβ Sequence
    Reaume, Andrew G., Howland, David S., Trusko, Stephen P., Savage, Mary J., Lang, Diane M., Greenberg, Barry D., Siman, Robert, Scott, Richard W. · 1996 · Journal of Biological Chemistry
81. Microglial degeneration in the aging brain - bad news for neurons?
    Streit, Wolfgang, J. · 2008 · Frontiers in Bioscience
82. Reduced effectiveness of Aβ1-42 immunization in APP transgenic mice with significant amyloid deposition
    Pritam Das, Michael Paul Murphy, Linda H. Younkin, Steven G. Younkin, Todd Eliot Golde · 2001 · Neurobiology of Aging
83. Rapid Microglial Response Around Amyloid Pathology after Systemic Anti-Aβ Antibody Administration in PDAPP Mice
    Koenigsknecht-Talboo, Jessica, Meyer-Luehmann, Melanie, Parsadanian, Maia, Garcia-Alloza, Monica, Finn, Mary Beth, Hyman, Bradley T., Bacskai, Brian J., Holtzman, David M. · 2008 · The Journal of Neuroscience
84. Amyloid-β Antibody Treatment Leads to Rapid Normalization of Plaque-Induced Neuritic Alterations
    Lombardo, Julianne A., Stern, Edward A., McLellan, Megan E., Kajdasz, Stephen T., Hickey, Gregory A., Bacskai, Brian J., Hyman, Bradley T. · 2003 · The Journal of Neuroscience
85. Excitotoxins in Neuronal Apoptosis and Necrosis
    Pierluigi Nicotera, Stuart A. Lipton · 1999 · Journal of Cerebral Blood Flow & Metabolism
86. A Precision Medicine Initiative for Alzheimer’s disease: the road ahead to biomarker-guided integrative disease modeling
    Hampel, H., O’Bryant, S. E., Durrleman, S., Younesi, E., Rojkova, K., Escott-Price, V., Corvol, J-C., Broich, K., Dubois, B., Lista, S. et al. · 2017 · Climacteric
87. Long amyloid beta-protein secreted from wild-type human neuroblastoma IMR-32 cells.
    A. Asami-Odaka, Y. Ishibashi, Takashi Kikuchi, C. Kitada, N. Suzuki · 1995 · Biochemistry
88. Targeting the Alpha 7 Nicotinic Acetylcholine Receptor to Reduce Amyloid Accumulation in Alzheimers Disease Pyramidal Neurons
    Michael R. D’Andrea, Robert G. Nagele · 2006 · Current Pharmaceutical Design
89. Treatment with an Amyloid-β Antibody Ameliorates Plaque Load, Learning Deficits, and Hippocampal Long-Term Potentiation in a Mouse Model of Alzheimer's Disease
    Hartman, Richard E., Izumi, Yukitoshi, Bales, Kelly R., Paul, Steven M., Wozniak, David F., Holtzman, David M. · 2005 · The Journal of Neuroscience
90. Transgenic mouse models of Alzheimer's disease: phenotype and application.
    2003 · PubMed
91. Many Neuronal and Behavioral Impairments in Transgenic Mouse Models of Alzheimer's Disease Are Independent of Caspase Cleavage of the Amyloid Precursor Protein
    Harris, Julie A., Devidze, Nino, Halabisky, Brian, Lo, Iris, Thwin, Myo T., Yu, Gui-Qiu, Bredesen, Dale E., Masliah, Eliezer, Mucke, Lennart · 2010 · The Journal of Neuroscience
92. A metabolomic study of the CRND8 transgenic mouse model of Alzheimer's disease
    Reza M. Salek, Jing Xia, Amy E. Innes, Brian C. Sweatman, Róbert Adalbert, Suzanne J. Randle, Eileen M. McGowan, Piers C. Emson, Julian Leether Griffin · 2010 · Neurochemistry International
93. Spatial relationship between synapse loss and β‐amyloid deposition in Tg2576 mice
    Hongxin Dong, Maureen V. Martin, Shawn Chambers, John G. Csernansky · 2006 · The Journal of Comparative Neurology
94. THE GENETICS AND MOLECULAR PATHOLOGY OF ALZHEIMER'S DISEASE
    Dennis J. Selkoe · 2000 · Neurologic Clinics
95. APP Transgenic Mice Tg2576 Accumulate Aβ Peptides That Are Distinct from the Chemically Modified and Insoluble Peptides Deposited in Alzheimer's Disease Senile Plaques
    Walter M. Kalback, M. Desiree Watson, Tyler A. Kokjohn, Yu‐Min Kuo, Nicole Weiss, Dean C. Luehrs, John C. Lopez, Daniel C. Brune, Sangram S. Sisodia, Matthias Staufenbiel et al. · 2001 · Biochemistry
96. Plaques, Tangles, and Memory Loss in Mouse Models of Neurodegeneration
    Eriksen, Jason L., Janus, Christopher G. · 2007 · Behavior Genetics
97. Astroglial Expression of Human α1-Antichymotrypsin Enhances Alzheimer-like Pathology in Amyloid Protein Precursor Transgenic Mice
    Mucke, Lennart, Yu, Gui-Qiu, McConlogue, Lisa, Rockenstein, Edward M., Abraham, Carmela R., Masliah, Eliezer · 2000 · The American Journal of Pathology
98. Measles Virus Infection in a Transgenic Model
    Michael B. A. Oldstone, Hanna A. Lewicki, Diane M. Thomas, Antoinette Tishon, Samuel Dales, John B. Patterson, Mari Manchester, Dirk Homann, Denise Naniche, Andreas Holz · 1999 · Cell
99. Vulnerability of Dentate Granule Cells to Disruption of Arc Expression in Human Amyloid Precursor Protein Transgenic Mice
    Jorge J. Palop, Jeannie Chin, Nga Bien‐Ly, Catherine M. Massaro, Bertrand Z. Yeung, Gui-Qiu Yu, Lennart Mucke · 2005 · Journal of Neuroscience
100. Brain Trauma Induces Massive Hippocampal Neuron Death Linked to a Surge in β-Amyloid Levels in Mice Overexpressing Mutant Amyloid Precursor Protein
     Smith, Douglas H., Nakamura, Michio, McIntosh, Tracy K., Wang, Jun, Rodríguez, Amarís, Chen, Xiao-Han, Raghupathi, Ramesh, Saatman, Kathryn E., Clemens, James, Schmidt, M. Luise et al. · 1998 · The American Journal of Pathology